Features

Cancer — TOP NEWS

Cancer-killing viruses show promise, spur interest from drug giants

[vvideo code=”44XRZUSM” autoplay=”yes”] Pharmaceutical giant Johnson & Johnson announced on May 2, 208 that it would pay up to US$1 billion to acquire a company that makes cancer-killing viruses. It was a striking show of support for a still-unproven treatment,